Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ANICURA IN CONNECTION WITH THE ACQUISITION OF DJURKLINIKEN I KATRINEHOLM
Mandate

VINGE ADVISES ANICURA IN CONNECTION WITH THE ACQUISITION OF DJURKLINIKEN I KATRINEHOLM

April 22, 2014

Vinge has advised AniCura (formerly Djursjukhusgruppen) in connection with the acquisition of Djurkliniken i Katrineholm Aktiebolag. AniCura is a leader in advanced veterinary care for dogs, cats and other companion animals. Established in 2011, AniCura is the first merger of companion animal hospitals in the Nordic region and is currently the only Nordic veterinary care group exclusively focused on companion animals.

Vinge’s team consisted of partner Jonas Bergström together with, among others, associates Gustav Jönsson, Erik Claesson, Niclas Winnberg and Emelie Klefbeck.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026